Skip to main content

Table 1 Secondary Outcome Measures

From: The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol

Secondary outcome measures (6 months and 12 months post initiation of HAART)

Type

Health outcomes

 

Self-reported adherence as a percentage

Binary

Suppressed HIV viral load (in copies)

Continuous

Immune reconstitution (change in CD4 T cell count from baseline)

 

Time to virological failure

Continuous

   Weight gain [lbs] and BMI

Time-to-event

   Occurrence of opportunistic infections (OIs)

Continuous

   Time to reporting of adverse drug events (ADEs)

Binary

   Deaths (all cause)

Time-to-event

Quality of life (QOL)

Time-to-event

   SF-12

 

   Satisfaction with care provided

Continuous

Social factors

Continuous

   Level of disclosure of HIV status

 

   Impression of stigma

Binary

   Family dyamics

Continuous

Economic factors

Continuous

   Employment attendance

 

   Household member school attendance

Continuous

   Cell phones lost/stolen

Continuous

  1. HAART = highly active antiretroviral therapy, SF-12 = short form 12 adapted for regional application in Kiswahili.